Cerity Partners’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $343K | Sell |
1,133
-278
| -20% | -$84.1K | ﹤0.01% | 2074 |
|
|
2025
Q1 | $467K | Sell |
1,411
-56
| -4% | -$18.5K | ﹤0.01% | 1788 |
|
|
2024
Q4 | $408K | Buy |
+1,467
| New | +$408K | ﹤0.01% | 1885 |
|
|
2024
Q3 | – | Sell |
-1,135
| Closed | -$318K | – | 2578 |
|
|
2024
Q2 | $318K | Sell |
1,135
-7
| -0.6% | -$1.96K | ﹤0.01% | 1785 |
|
|
2024
Q1 | $305K | Buy |
+1,142
| New | +$305K | ﹤0.01% | 1858 |
|
|
2023
Q2 | – | Sell |
-914
| Closed | -$221K | – | 1833 |
|
|
2023
Q1 | $221K | Buy |
914
+89
| +11% | +$21.6K | ﹤0.01% | 1663 |
|
|
2022
Q4 | $239K | Buy |
+825
| New | +$239K | ﹤0.01% | 1241 |
|